Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Autoimmune Drugs Markets in China
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More
-
Autoimmune Drugs Companies in China
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More
-
Autoimmune Drugs Industry Forecasts - China Focus
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Lymphopenia Therapeutics Market by Product and Geography - Forecast and Analysis 2019-2023
... North America, and ROW. In 2018, the acquired lymphopenia segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising incidence of diseases from ... Read More
-
Global Autoimmune Partnering 2014-2019: Deal trends, players and financials
... in Autoimmune partnering deals Financial deal terms for headline, upfront and royalty by stage of development Autoimmune partnering agreement structure Autoimmune partnering contract documents Top Autoimmune deals by value Most active Autoimmune dealmakers Most of ... Read More
-
Autoimmune Hemolytic Anemia Therapeutics Market by Product and Geography - Global Forecast & Analysis 2019-2023
... anemia therapeutics in Asia, Europe, North America, and ROW. In 2018, the corticosteroids segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the strong ... Read More
-
Autoimmune Hepatitis Pipeline Insight, 2019
... picture of the Autoimmune Hepatitis pipeline landscape is provided which includes the disease overview and Autoimmune Hepatitis treatment guidelines. The assessment part of the report embraces, in depth Autoimmune Hepatitis commercial assessment and clinical assessment ... Read More
-
Interleukin Inhibitors Market by Product and Geography - Global Forecast and Analysis 2019-2023
... and other Interleukin inhibitors. Our analysis also considers the sales of Interleukin inhibitors in Asia, Europe, North America, and ROW. In 2018, the Interleukin-23 inhibitors segment had a significant market share, and this trend is ... Read More
-
Lupus Nephritis (LN)- Epidemiology Forecast to 2028
... United Kingdom), and Japan. Geography Covered • The United States • EU5 (Germany, France, Italy, Spain and the United Kingdom) • Japan Study Period: 2017-2028 Lupus Nephritis Epidemiology The Lupus Nephritis (LN) epidemiology division provide ... Read More
-
Generalized Myasthenia Gravis (gMG)—Epidemiology Forecast to 2028
... and the United Kingdom), and Japan. Geography Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2017–2028 Generalized Myasthenia Gravis Epidemiology The Generalized Myasthenia Gravis ... Read More
-
Sjogren’s Syndrome (SS)- Epidemiology Forecast to 2028
... the United Kingdom), and Japan. Geography Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2017–2028 Sjogren’s Syndrome Epidemiology The Sjogren’s Syndrome epidemiology division provide ... Read More
-
Sjogren’s Syndrome (SS)—Market Insights, Epidemiology and Market Forecast—2028
... States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, the current and forecasted market size of Sjogren’s Syndrome ... Read More
-
Lupus Nephritis (LN) - Market Insights, Epidemiology and Market Forecast-2028
... States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Lupus Nephritis (LN) ... Read More
-
Generalized Myasthenia Gravis (gMG)—Market Insights, Epidemiology, and Market Forecast—2028
... States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The report provides the current treatment practices, emerging drugs, market share of the individual therapies, and the current and forecasted market size of Generalized ... Read More
-
Global Janus Kinase (JAK) Inhibitors Market 2019-2023
... such as JAK1, JAK2, JAK3, and TYK2. The inhibition of these enzymes helps interfere with the JAK-STAT signaling pathway, which has been found to play a key role in the development of various autoimmune disorders ... Read More
-
Cutaneous Lupus Erythematosus (CLE) - Market Insights, Epidemiology and Market Forecast-2028
... Erythematosus in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size ... Read More
-
Systemic Lupus Erythematosus: Programs Targeting Cytokine and Growth Factor Signaling Dominate First-in-Class Pipeline
... characterized by a high level of first-in-class innovation when compared to other therapy areas and the industry as a whole. Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ ... Read More
-
Autoimmune Disease Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025
... By Test Type (Routine Laboratory Tests, Inflammatory Markers, Autoantibodies and Immunologic Tests, and Others), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjogren’s syndrome, Thyroiditis, and Others), By End User (Clinical Laboratories, Hospitals, and Others) and ... Read More
-
Global Primary Biliary Cholangitis Therapeutics Market 2019-2023
... of time. Technavio’s primary biliary cholangitis therapeutics market analysis considers sales of OCALIVA, ursodiol, and others. Our analysis also considers the sales of primary biliary cholangitis therapeutics in Asia, Europe, North America, ROW. In 2018, ... Read More
-
Global C-Reactive Protein Test Market 2019-2023
... diabetes, stroke, cancer, arthritis, and others are responsible for seven out of 10 deaths among the people in the US. In addition, autoimmune diseases are a key health concern, further, driving the demand for CRP ... Read More
-
Autoimmune Disease Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)
... rising awareness about autoimmune diseases through programs of research, education, support, and advocacy is a key factor boosting the usage rates of autoimmune disease diagnostics, globally. The United States has the highest incidence of autoimmune ... Read More
-
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2019
... Review, H1, 2019 provides an overview of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Cutaneous Lupus ... Read More
-
Cutaneous Lupus Erythematosus Global Clinical Trials Review, H1, 2019
... report provides top line data relating to the clinical trials on Cutaneous Lupus Erythematosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
North America Autoimmune Disease Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)
... boosting the usage rates of autoimmune disease diagnostics market in North America. The United States has the highest incidence of autoimmune diseases, where about 50 million patients suffer from autoimmune diseases. In 2017, according to ... Read More
-
Global Myasthenia Gravis Market Research Report Forecast to 2023
... and Clinics, Diagnostic Centers and Academic and Research Organizations) and By Region-Global Forecast Till 2023 Market analysis Myasthenia gravis (MG) is an immune system neuromuscular illness, its essential effect incorporates a reduction in the convergence ... Read More
